Keith A. Lawson

National Institutes of Health — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

15h-index2.6kcitations85works4.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal and related cancers(26), Cancer Research and Treatments(21), Renal cell carcinoma treatment(18), Virus-based gene therapy research(18), Health Systems, Economic Evaluations, Quality of Life(11)

Publications85 total

Using Mendelian randomization to investigate etiologic heterogeneity across renal cell carcinoma subtypes
International Journal of Epidemiology·2025
37Integrative multi-omic characterization of the immune landscape in renal cell carcinoma
The Oncologist·2025Open Access
Renal surgery following HIF-2α antagonist therapy: Surgical indications, outcomes and growth kinetics
Urologic Oncology Seminars and Original Investigations·2025Open Access
A global genetic interaction map of a human cell reveals conserved principles of genetic networks
2025· 5 citedOpen Access
Quantitative analysis of genetic interactions in human cells from genome-wide CRISPR-Cas9 screens
2025· 2 citedOpen Access
Characterization of the Pheochromocytoma-Predominant Subgroup of von Hippel-Lindau Disease
Urology·2025· 1 cited
Transcriptome- and proteome-wide association studies identify genes associated with renal cell carcinoma
The American Journal of Human Genetics·2024· 9 citedOpen Access
De-clear cell differentiated renal cell carcinoma — a new therapeutic target
Nature Reviews Urology·2024· 1 cited
Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions
Nature Genetics·2024· 41 cited
PD18-03 NATURAL HISTORY OF METASTATIC RENAL CELL CARCINOMA (RCC) ASSOCIATED WITH HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CARCINOMA (HLRCC)
The Journal of Urology·2024
PD33-06 RENAL SURGERY FOLLOWING HIF2ALPHA; ANTAGONIST THERAPY: GROWTH KINETICS AND SURGICAL OUTCOMES
The Journal of Urology·2024
Abstract 4215: Single-cell proteomic characterization of the tumor microenvironment in humanized NOG-EXL patient-derived xenograft (PDX) models
Cancer Research·2024
Abstract B017: Single-cell proteogenomic profiling reveals immune cell networks in renal cell carcinoma
Cancer Immunology Research·2023
Abstract A040: Spatially resolved immune cell networks in renal cell carcinoma
Cancer Immunology Research·2023
Normal and pathogenic variation of <i>RFC1</i> repeat expansions: implications for clinical diagnosis
Brain·2023· 66 citedOpen Access
Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisions
European Radiology·2023· 22 cited
Supplemental Figure 3 from Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma
2023Open Access
Supplemental Figure 5 from Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma
2023Open Access
Supplemental Figure 1 from Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma
2023Open Access
Supplemental Figure 3 from Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Antonio Finelli(21), Olli Saarela(14), Jason Moffat(9), Robert Abouassaly(7), Amy H.Y. Tong(6), Michael Aregger(6), Patricia Mero(6), Kevin R. Brown(6), Andrea Habsid(5), Matej Ušaj(5), Maximilian Billmann(5), Mahfuzur Rahman(5), Chad L. Myers(5), Brenda Andrews(5), Charles Boone(5), Gary D. Bader(5), Jolanda van Leeuwen(4), Olga Sizova(4), Ryan Climie(4), David Tieu(4)